Skip to content
Screener

Viatris VTRS Other income, net (Note 6)

Other income, net (Note 6) at other companies

Pfizer logo
PfizerPFE
$3.72B+603%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$468K-127%
AMP
Amphastar PharmaceuticalsAMPH
$3.19M+111%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
-$473K-115%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$653K-59.3%
Merck & Co. logo
Merck & Co.MRK
-$99M-1,514%

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$18.97B+84.7%
Enterprise value$31.71B+29.6%
P/S1.3×+0.6×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Total operating expenses1,450.21,099.92,687.15,143.3
Earnings (loss) from operations6.3233.0(73.4)(2,649.2)
Interest expense120.7116.6240.8232.1
Other (income) expense, net(50.4)333.5(2.9)432.8
Loss before income taxes(64.0)(217.1)(311.3)(3,314.1)
Income tax provision (benefit)54.8(212.5)(368.9)(267.5)
Net (loss) earnings$(118.8)$(4.6)$57.6$(3,046.6)
(Loss) earnings per share attributable to Viatris Inc. shareholders

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's other income, net (note 6)?
Viatris (VTRS) reported other income, net (note 6) of $50.4M in Q2 2026.
How has Viatris's other income, net (note 6) changed year-over-year?
Viatris's other income, net (note 6) increased by 115.1% year-over-year, from -$333.5M to $50.4M.
What is the long-term trend for Viatris's other income, net (note 6)?
Over 3 years (2021 to 2025), Viatris's other income, net (note 6) has grown at a 350.6% compound annual growth rate (CAGR), from $5.8M to -$530.6M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Viatris's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude